Superdisintegrants Market Size To Reach $769.8 Million By 2030

Superdisintegrants Market Growth & Trends

The global superdisintegrants market size is expected to reach USD 769.8 million by 2030, registering to grow at a CAGR of 5.3% from 2024 to 2030 according to a new report by Grand View Research, Inc. Superdisintegrants help in the disintegration of tablet or capsule content into small particles and create a greater surface area for speedy drug release.

A number of fast disintegrating tablets such as salbutamol sulphate, and cetirizine hydrochloride in tablet/capsule dosage form for respiratory disorders (bronchitis, asthma, and coughing) are formulated for pediatric and geriatric patients, due to their difficulty or discomfort in swallowing. Superdisintegrant such as crospovidone, croscarmellose sodium, and sodium starch glycolate are used in optimized concentration to formulate such tablets/capsules along with different binders such as MCC and PVP K-30.

 Request a free sample copy or view report summary: Superdisintegrants Market Report

Superdisintegrants Market Report Highlights

• The market study suggests that crospovidone dominated the overall market in 2023. Crospovidone is completely insoluble in water and rapidly disperses and swells in water.  It has the greatest rate of swelling and surface area to volume ratio compared to other disintegrants.

• Tablets and capsules commanded a dominant market share of 62.3% in 2023, primarily driven by the extensive use of crospovidone as an excipient. Crospovidone's advantageous properties, including inhibition of recrystallization and enhancement of dissolution and disintegration of solid dosage forms, translate to improved swallowability for both geriatric and pediatric patients..

• The mouth-dissolving film segment is expected to grow at the highest growth rate during the forecast period. It is the preferred choice for patients as compared to tablets and capsules due to the greater flexibility and comfort of the former.

• North America dominated the regional segment with the largest revenue share in 2023, due to number of superdisintegrants manufacturers operating in the region and prolific research and development initiatives

• Some of the major companies operating in this market are BASF SE; Ashland; DuPont.; Roquette Frères.; DFE Pharma; JRS PHARMA; Asahi Kasei Corporation.; Merck KGaA; Corel Pharma Chem and others.

Superdisintegrants Market Segmentation

Grand View Research has segmented the global superdisintegrants market based on product, form and region:

Superdisintegrants Product Outlook (Revenue, USD Million, 2018 - 2030)

• Croscarmellose sodium

• Crospovidone

• Sodium Starch Glycolate

• Ion Exchange Resin

• Others

Superdisintegrants Form Outlook (Revenue, USD Million, 2018 - 2030)

• Tablets and Capsules

• Mouth-dissolving Films

Superdisintegrants Regional Outlook (Revenue, USD Million, 2018 - 2030) 

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • Saudi Arabia

  • UAE

  • South Africa

  • Kuwait

List of Key Players in Superdisintegrants Market

• BASF SE

• Ashland

• DuPont.

• Roquette Frères.

• DFE Pharma

• JRS PHARMA

• Asahi Kasei Corporation.

• Merck KGaA

• Corel Pharma Chem.

• NIPPON SODA CO., LTD.